Skip to content
OpenCapital
Get started

Revelation Biosciences, Inc. REVB Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$7.08Miss by $1.72
EPS estimate-$5.36

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.83

Versus estimates

Revenue

Q4 2024$27.0K

Diluted EPS

Q1 2026-$2.71Miss by $1.56Q4 2025-$1.65Beat by $2.01
Q3 2025-$7.08Miss by $1.72
Q2 2025-$7.01Miss by $2.55Q1 2025-$6.33Beat by $14.31Q4 2024-$14.94Miss by $5.34

Ask the moment Revelation Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Revelation Biosciences, Inc. report Q3 2025 earnings?
Revelation Biosciences, Inc. (REVB) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Revelation Biosciences, Inc.'s Q3 2025 revenue and EPS?
Revelation Biosciences, Inc. reported eps of $-7.08 for Q3 2025.
Did Revelation Biosciences, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-5.36 by $1.72.
How did Revelation Biosciences, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 82.4% from $-40.32.
Where can I find Revelation Biosciences, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269696) and the 10-Q periodic report (0001193125-25-269450) directly on SEC EDGAR. The filing index links above go to sec.gov.